Pulmonary Rehabilitation and Smoking

Smoking Clinical Trial

Official title:

Effectiveness of Pulmonary Rehabilitation in Smoker Patients With COPD

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03671187
• Other study ID #: IKCU
• Status: Completed
• Phase: N/A
• Start date: January 2015
• Est. completion date: August 2018

Study information

• Verified date: September 2018
• Source: Izmir Katip Celebi University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients.

Description:

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients. People who have completed the PR program, smoking and not smoking will be included into the study.

Data of carbon monoxide diffusion test, body plethysmography, 6-min walk test, blood gas analysis, mMRC dyspnea scale, hospital anxiety depression scale, SGRQ and SF-36 quality of life questionnaire performed before and after the program will be analyzed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 31
• Est. completion date: August 2018
• Est. primary completion date: August 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• COPD patients completed 8 PR program

Exclusion Criteria:

• Never smoked patients

• Participated PR program in last year

Related Conditions & MeSH terms

• Rehabilitation; Tobacco Use
• Smoking

Intervention

Other:
• Exercise
8 week exercise program

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Izmir Katip Celebi University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Six minute walk test	It was performed in a 30-meter long corridor in accordance with American Thoracic	6 minutes
Secondary	Pulmonary Function Test	It was used for assessment of lung functions	20 minutes
Secondary	Dyspnea Severity	MMRC Dyspnea Scale (0: no dyspnea, 4: very severe dyspnea), It was used for dyspnea that patients felt during their daily activities.	5 minues
Secondary	St. George Disease Related Quality of Life Scale	A disease-specific quality of life scale (Max. score:100, lower score means better quality of life level)	20 minutes
Secondary	Short Form-36 Quality of Life Survey	A health related quality of life scale, Short Form-36 Quality of Life Survey (Max. score:100, higher score means better quality of life level)	25 minutes
Secondary	Hospital Anxiety and Depression Inventory	It was used for assessment of anxiety and depression	20 minutes